Executive readout · one minute
Webcast research workspace
Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.
CTMX
$2.04
+0.00%
CTMX
· CytomX Therapeutics, Inc.
$2.04
+0.00 (+0.00%)
At close · Nov 13
Return incl. dividend (before tax)
Play latest call
Q3 2026 earnings call transcript
Market Cap
$444.73M
Shares
218.00M
Volume · Nov 13
2.72M
Avg daily vol (3M)
4.16M
All webcasts
Earnings call · FY2025 Q1
CytomX Therapeutics, Inc. (CTMX) Q1 2025 Earnings Call
Revenue
$50.92M
+22.8% YoY
Net income
$23.52M
+70.6% YoY
Research coverage
2 live sources
Open each available source without leaving this research workspace.
Research materials
Open the source you need; every reader stays inside this workspace.
SEC filing · Item 2.02
8-K earnings release
Filed May 12, 2025 · complete as-filed document
SEC periodic report
10-Q report
Filed May 12, 2025 · complete as-filed document